Key facts
- It has raised $3.1M; the latest was Seed Round ($1.6M) in May 2025.
- Notable investors include Archangel Ventures, Bupa Ventures, The George Institute for Global Health, UNSW Founders.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Vively
- ·The full record, as it builds
Funding rounds
No funding rounds for Vively are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vively
Developer of a health tracking device designed to help manage the health conditions of users. The company's platform tracks glucose levels and other health indicators through sensors to suggest food and wellness scores and sends real-time insights on how users' diet, exercise, sleep, and stress affect their health based on their glucose levels, enabling users to maintain a healthy diet and lifestyle.
- Sector
- Healthcare
- HQ
- Sydney, Australia
- Founded
- 2020
- Employees
- 18
- Website
- vively.com.au/
- Ownership
- Privately Held (backing)
Vively doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vively shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vively in its N-PORT filings yet. We sweep new filings monthly.